首页 > 最新文献

Journal of the American College of Clinical Pharmacy : JACCP最新文献

英文 中文
Part II: Recorded webcast: Vaping 第二部分:网络广播录音:吸烟
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-10 DOI: 10.1002/jac5.2018
Chasity M. Shelton Pharm.D., FCCP
{"title":"Part II: Recorded webcast: Vaping","authors":"Chasity M. Shelton Pharm.D., FCCP","doi":"10.1002/jac5.2018","DOIUrl":"https://doi.org/10.1002/jac5.2018","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142170209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Connecting medication therapy problems with social determinants of health: A proposed framework 将药物治疗问题与健康的社会决定因素联系起来:拟议框架
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-10 DOI: 10.1002/jac5.2016
Kylee A. Funk Pharm.D., Lindsay A. Sorge Pharm.D., Deborah L. Pestka Pharm.D., Ph.D.
{"title":"Connecting medication therapy problems with social determinants of health: A proposed framework","authors":"Kylee A. Funk Pharm.D., Lindsay A. Sorge Pharm.D., Deborah L. Pestka Pharm.D., Ph.D.","doi":"10.1002/jac5.2016","DOIUrl":"https://doi.org/10.1002/jac5.2016","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142169929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collaborative leadership exists within all our scopes of practice 在我们的所有业务范围内都存在合作领导力
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-10 DOI: 10.1002/jac5.2017
Rosalyn Padiyara Vellurattil Pharm.D., Rebecca M. Singer DNP
{"title":"Collaborative leadership exists within all our scopes of practice","authors":"Rosalyn Padiyara Vellurattil Pharm.D., Rebecca M. Singer DNP","doi":"10.1002/jac5.2017","DOIUrl":"https://doi.org/10.1002/jac5.2017","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142169940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Part I: Case series: Pancreatitis 第一部分:病例系列:胰腺炎
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-10 DOI: 10.1002/jac5.2019
Abigail M. Yancey Pharm.D., FCCP
{"title":"Part I: Case series: Pancreatitis","authors":"Abigail M. Yancey Pharm.D., FCCP","doi":"10.1002/jac5.2019","DOIUrl":"https://doi.org/10.1002/jac5.2019","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142170192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pharmacy and patient safety: Have we reached a golden era? 临床药学与患者安全:我们是否已进入黄金时代?
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-02 DOI: 10.1002/jac5.2012
Michael E. Ernst Pharm.D., FCCP, Michelle A. Fravel Pharm.D., FCCP
{"title":"Clinical pharmacy and patient safety: Have we reached a golden era?","authors":"Michael E. Ernst Pharm.D., FCCP, Michelle A. Fravel Pharm.D., FCCP","doi":"10.1002/jac5.2012","DOIUrl":"https://doi.org/10.1002/jac5.2012","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teaching learners to identify and reduce the spread of medical misinformation 教会学习者识别和减少医疗错误信息的传播
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-07-31 DOI: 10.1002/jac5.2014
Steven Theodore Johnson Pharm.D., Micheline Andel Goldwire Pharm.D., M.S., M.A., Maha Abdalla Pharm.D., Ph.D., Ashish Advani Pharm.D., Abdullah M. Alhammad Pharm.D., Keri C. Anderson Pharm.D., Allison Bernknopf Pharm.D., MSMI, Matthew L. Blommel Pharm.D., Rachel Brunner Pharm.D., JorDonna Frazier Pharm.D., Prit Gor B.S., Rena Gosser Pharm.D., Heather Ipema Pharm.D., Karen L. Kier Ph.D., M.Sc., FCCP, Audrey Kostrzewa Pharm.D., MPH, Daniel Majerczyk Pharm.D., Ed.M., FCCP, Radha Manian Ph.D., Erin Maxwell Pharm.D., Dianne May Pharm.D., FCCP, J. Russell May Pharm.D., Faria Munir Pharm.D., M.S., Ife Okafar Pharm.D., Jennifer Phillips Pharm.D., FCCP, Alia A. Poore Pharm.D., Maha Saad Pharm.D., Julie B. Sibbesen Pharm.D., Christine D. Sommer Pharm.D., M.A.

Pharmacists play a key role in helping to identify and combat the spread of medical misinformation. To do this effectively, pharmacists need to be equipped with skills and tools to respond to medical misinformation as it relates to patient care. The lack of peer-reviewed research on how to approach medical misinformation illustrates the need for specific strategies on how to identify, combat, and report medical misinformation. This article describes practical tactics pharmacists can use to teach learners the knowledge and skills necessary to reduce the spread of medical misinformation from various sources, including social media and artificial intelligence.

药剂师在帮助识别和打击医疗误导传播方面发挥着关键作用。要有效地做到这一点,药剂师需要掌握应对与患者护理相关的医疗误导信息的技能和工具。关于如何处理医疗误导的同行评议研究不足,这说明需要制定具体的策略来识别、打击和报告医疗误导。本文介绍了药剂师可以用来向学习者传授必要知识和技能的实用策略,以减少来自各种渠道(包括社交媒体和人工智能)的医疗误导信息的传播。
{"title":"Teaching learners to identify and reduce the spread of medical misinformation","authors":"Steven Theodore Johnson Pharm.D.,&nbsp;Micheline Andel Goldwire Pharm.D., M.S., M.A.,&nbsp;Maha Abdalla Pharm.D., Ph.D.,&nbsp;Ashish Advani Pharm.D.,&nbsp;Abdullah M. Alhammad Pharm.D.,&nbsp;Keri C. Anderson Pharm.D.,&nbsp;Allison Bernknopf Pharm.D., MSMI,&nbsp;Matthew L. Blommel Pharm.D.,&nbsp;Rachel Brunner Pharm.D.,&nbsp;JorDonna Frazier Pharm.D.,&nbsp;Prit Gor B.S.,&nbsp;Rena Gosser Pharm.D.,&nbsp;Heather Ipema Pharm.D.,&nbsp;Karen L. Kier Ph.D., M.Sc., FCCP,&nbsp;Audrey Kostrzewa Pharm.D., MPH,&nbsp;Daniel Majerczyk Pharm.D., Ed.M., FCCP,&nbsp;Radha Manian Ph.D.,&nbsp;Erin Maxwell Pharm.D.,&nbsp;Dianne May Pharm.D., FCCP,&nbsp;J. Russell May Pharm.D.,&nbsp;Faria Munir Pharm.D., M.S.,&nbsp;Ife Okafar Pharm.D.,&nbsp;Jennifer Phillips Pharm.D., FCCP,&nbsp;Alia A. Poore Pharm.D.,&nbsp;Maha Saad Pharm.D.,&nbsp;Julie B. Sibbesen Pharm.D.,&nbsp;Christine D. Sommer Pharm.D., M.A.","doi":"10.1002/jac5.2014","DOIUrl":"https://doi.org/10.1002/jac5.2014","url":null,"abstract":"<p>Pharmacists play a key role in helping to identify and combat the spread of medical misinformation. To do this effectively, pharmacists need to be equipped with skills and tools to respond to medical misinformation as it relates to patient care. The lack of peer-reviewed research on how to approach medical misinformation illustrates the need for specific strategies on how to identify, combat, and report medical misinformation. This article describes practical tactics pharmacists can use to teach learners the knowledge and skills necessary to reduce the spread of medical misinformation from various sources, including social media and artificial intelligence.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142170316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State of the union: A review of state-based laws and regulations supporting pharmacist payment for clinical services 联盟状况:各州支持药剂师临床服务付费的法律法规回顾
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-07-26 DOI: 10.1002/jac5.2008
Advancing Pharmacist Payment Parity Workgroup

Integrating pharmacists into interdisciplinary care models is essential for achieving the Quintuple Aim in health care, which emphasizes improving patient outcomes, enhancing patient and provider experiences, reducing costs, and advancing health equity. Despite expanded scopes of practice that facilitate collaborative models, pharmacists often face significant barriers due to inconsistent and insufficient reimbursement for their clinical services. This review seeks to address these challenges by focusing on state-based legislation and regulations that establish payment parity or create pathways for reimbursing pharmacist clinical services. Through a narrative review, this article systematically compares different states' approaches to pharmacist reimbursement by examining affected payers, billable services, and other pertinent details. The ultimate goal is to propose model characteristics for states considering the enhancement or development of legislation and regulations to ensure equitable payment mechanisms for pharmacist services. By providing a comprehensive overview of existing models and identifying effective legislative characteristics, this review aims to inform and empower pharmacists and their advocates with a better understanding of reimbursement regulations and to inspire community-driven advocacy for equitable compensation, thus supporting the integration of pharmacists as essential health care providers.

将药剂师纳入跨学科护理模式对于实现医疗保健的 "五重目标 "至关重要。"五重目标 "强调改善患者疗效、提升患者和医疗服务提供者的体验、降低成本以及促进医疗公平。尽管执业范围的扩大促进了合作模式的发展,但由于药剂师临床服务的补偿不一致且不足,药剂师往往面临着巨大的障碍。本综述旨在通过重点关注各州的立法和法规来应对这些挑战,这些立法和法规建立了药剂师临床服务的同等支付或创建了药剂师临床服务的补偿途径。通过叙述性综述,本文系统地比较了不同州的药剂师报销方法,研究了受影响的支付方、可结算的服务及其他相关细节。最终目的是为各州在考虑加强或制定法律法规时提出模式特征,以确保药剂师服务的公平支付机制。通过对现有模式进行全面概述并确定有效的立法特征,本综述旨在为药剂师及其拥护者提供信息,使其更好地了解补偿法规,并激发社区对公平补偿的拥护,从而支持将药剂师整合为基本医疗服务提供者。
{"title":"State of the union: A review of state-based laws and regulations supporting pharmacist payment for clinical services","authors":"Advancing Pharmacist Payment Parity Workgroup","doi":"10.1002/jac5.2008","DOIUrl":"10.1002/jac5.2008","url":null,"abstract":"<p>Integrating pharmacists into interdisciplinary care models is essential for achieving the Quintuple Aim in health care, which emphasizes improving patient outcomes, enhancing patient and provider experiences, reducing costs, and advancing health equity. Despite expanded scopes of practice that facilitate collaborative models, pharmacists often face significant barriers due to inconsistent and insufficient reimbursement for their clinical services. This review seeks to address these challenges by focusing on state-based legislation and regulations that establish payment parity or create pathways for reimbursing pharmacist clinical services. Through a narrative review, this article systematically compares different states' approaches to pharmacist reimbursement by examining affected payers, billable services, and other pertinent details. The ultimate goal is to propose model characteristics for states considering the enhancement or development of legislation and regulations to ensure equitable payment mechanisms for pharmacist services. By providing a comprehensive overview of existing models and identifying effective legislative characteristics, this review aims to inform and empower pharmacists and their advocates with a better understanding of reimbursement regulations and to inspire community-driven advocacy for equitable compensation, thus supporting the integration of pharmacists as essential health care providers.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141800607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in the approach to guideline-directed medical therapy in patients with heart failure with reduced ejection fraction: A survey of cardiologists, internists, and pharmacists 射血分数减低的心力衰竭患者在指南指导下接受药物治疗的方法存在差异:对心脏病专家、内科医生和药剂师的调查
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-07-23 DOI: 10.1002/jac5.2013
Lana Alhashimi Pharm.D., David J. Cordwin Pharm.D., Jessica Guidi M.D., Scott L. Hummel M.D., M.S., Todd M. Koelling M.D., Michael P. Dorsch Pharm.D., M.S.

Introduction

Guideline-directed medical therapy (GDMT) has significantly improved outcomes in patients with heart failure with reduced ejection fraction. However, GDMT prescribing remains suboptimal. The purpose of this study was to survey cardiologists, internists, and pharmacists on their approach to GDMT prescribing.

Methods

A survey containing 20 clinical vignettes of patients with heart failure with reduced ejection fraction was answered by 127 cardiologists, 68 internists, and 89 pharmacists. Each vignette presented options for adjusting GDMT. Responses were dichotomized to the answer of interest. A mixed-effect model was used to calculate the odds of changing GDMT between pharmacists and physicians.

Results

Pharmacists were more likely to make changes to GDMT compared with internists (92.1 vs. 82%; odds ratio [OR] 3.02 [1.50–6.06]; p = 0.002). In medically naïve patients, pharmacists were more likely to initiate beta-blockers than internists (45.4 vs. 32.0%; OR 2.19 [1.00–4.79], p = 0.049). Pharmacists were more likely than both internists and cardiologists to initiate mineralocorticoid receptor antagonists (34.4 vs. 11.5%; OR 4.95 [2.41–10.18]; p < 0.001 and 34.4 vs. 13.9%; OR 3.95 [2.16–7.21]; p < 0.001). Pharmacists were more likely than both internists and cardiologists to titrate beta-blockers (30.9 vs. 16.4%; OR 3.15 [1.92–5.19]; p < 0.001 and 30.9 vs. 22.0%; OR 1.88 [0.18–2.87]; p = 0.0030). Pharmacists were more likely than internists to titrate angiotensin receptor-neprilysin inhibitors (61.8 vs. 34.1%; OR 3.54 [1.50–8.39]; p = 0.004).

Conclusions

The survey results show pharmacists were more likely to make any adjustments to GDMT than internists and cardiologists. Pharmacists prefer adding spironolactone and titrating beta-blockers compared with cardiologists and internists. Compared with only internists, pharmacists were more likely to initiate beta-blockers and titrate the dose of angiotensin receptor-neprilysin inhibitor.

指南指导下的药物治疗(GDMT)大大改善了射血分数降低的心力衰竭患者的预后。然而,GDMT 的处方仍然不够理想。这项研究旨在调查心脏病专家、内科医生和药剂师开具 GDMT 处方的方法。127 名心脏病专家、68 名内科医生和 89 名药剂师回答了包含 20 个射血分数减低型心衰患者临床案例的调查问卷。每个小故事都提供了调整 GDMT 的选项。回答被二分为感兴趣的答案。采用混合效应模型计算药剂师和内科医生改变 GDMT 的几率。与内科医生相比,药剂师更有可能改变 GDMT(92.1% 对 82%;几率比 [OR] 3.02 [1.50-6.06];P = 0.002)。在医疗条件不成熟的患者中,药剂师比内科医生更有可能开始使用β-受体阻滞剂(45.4% 对 32.0%;OR 2.19 [1.00-4.79],p = 0.049)。药剂师比内科医生和心脏病专家更有可能使用矿质皮质激素受体拮抗剂(34.4 vs. 11.5%;OR 4.95 [2.41-10.18];p < 0.001 和 34.4 vs. 13.9%;OR 3.95 [2.16-7.21];p < 0.001)。药剂师比内科医生和心脏病专家更有可能滴定β-受体阻滞剂(30.9 vs. 16.4%;OR 3.15 [1.92-5.19];p < 0.001 和 30.9 vs. 22.0%;OR 1.88 [0.18-2.87];p = 0.0030)。药剂师比内科医生更有可能滴定血管紧张素受体-肾上腺素抑制剂(61.8% vs. 34.1%;OR 3.54 [1.50-8.39];p = 0.004)。与心脏病专家和内科医生相比,药剂师更倾向于添加螺内酯和滴定β-受体阻滞剂。与仅有的内科医生相比,药剂师更倾向于开始使用β-受体阻滞剂和滴定血管紧张素受体-奈普利辛抑制剂的剂量。
{"title":"Differences in the approach to guideline-directed medical therapy in patients with heart failure with reduced ejection fraction: A survey of cardiologists, internists, and pharmacists","authors":"Lana Alhashimi Pharm.D.,&nbsp;David J. Cordwin Pharm.D.,&nbsp;Jessica Guidi M.D.,&nbsp;Scott L. Hummel M.D., M.S.,&nbsp;Todd M. Koelling M.D.,&nbsp;Michael P. Dorsch Pharm.D., M.S.","doi":"10.1002/jac5.2013","DOIUrl":"10.1002/jac5.2013","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Guideline-directed medical therapy (GDMT) has significantly improved outcomes in patients with heart failure with reduced ejection fraction. However, GDMT prescribing remains suboptimal. The purpose of this study was to survey cardiologists, internists, and pharmacists on their approach to GDMT prescribing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A survey containing 20 clinical vignettes of patients with heart failure with reduced ejection fraction was answered by 127 cardiologists, 68 internists, and 89 pharmacists. Each vignette presented options for adjusting GDMT. Responses were dichotomized to the answer of interest. A mixed-effect model was used to calculate the odds of changing GDMT between pharmacists and physicians.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Pharmacists were more likely to make changes to GDMT compared with internists (92.1 vs. 82%; odds ratio [OR] 3.02 [1.50–6.06]; <i>p</i> = 0.002). In medically naïve patients, pharmacists were more likely to initiate beta-blockers than internists (45.4 vs. 32.0%; OR 2.19 [1.00–4.79], <i>p</i> = 0.049). Pharmacists were more likely than both internists and cardiologists to initiate mineralocorticoid receptor antagonists (34.4 vs. 11.5%; OR 4.95 [2.41–10.18]; <i>p</i> &lt; 0.001 and 34.4 vs. 13.9%; OR 3.95 [2.16–7.21]; <i>p</i> &lt; 0.001). Pharmacists were more likely than both internists and cardiologists to titrate beta-blockers (30.9 vs. 16.4%; OR 3.15 [1.92–5.19]; <i>p</i> &lt; 0.001 and 30.9 vs. 22.0%; OR 1.88 [0.18–2.87]; <i>p</i> = 0.0030). Pharmacists were more likely than internists to titrate angiotensin receptor-neprilysin inhibitors (61.8 vs. 34.1%; OR 3.54 [1.50–8.39]; <i>p</i> = 0.004).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The survey results show pharmacists were more likely to make any adjustments to GDMT than internists and cardiologists. Pharmacists prefer adding spironolactone and titrating beta-blockers compared with cardiologists and internists. Compared with only internists, pharmacists were more likely to initiate beta-blockers and titrate the dose of angiotensin receptor-neprilysin inhibitor.</p>\u0000 </section>\u0000 </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.2013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141810144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on “Navigating obstacles: Perspectives of US pharmacy residency directors on non-US candidates for PGY-1 residencies: A survey-based research” 对 "克服障碍:美国药学住院实习主任对 PGY-1 住院实习非美国候选人的看法:基于调查的研究"
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-07-09 DOI: 10.1002/jac5.1992
Chi-Hua Lu Pharm.D., Edward M. Bednarczyk Pharm.D., FCCP
{"title":"Response to Comment on “Navigating obstacles: Perspectives of US pharmacy residency directors on non-US candidates for PGY-1 residencies: A survey-based research”","authors":"Chi-Hua Lu Pharm.D.,&nbsp;Edward M. Bednarczyk Pharm.D., FCCP","doi":"10.1002/jac5.1992","DOIUrl":"https://doi.org/10.1002/jac5.1992","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141583796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Professional and career development needs of clinical pharmacists in settings outside academia” 就 "学术界以外环境中临床药师的专业和职业发展需求 "发表评论
IF 1.3 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-07-09 DOI: 10.1002/jac5.1990
G. Christina Gutierrez Pharm.D., Rebecca Brady Pharm.D., Elizabeth O. Hand Pharm.D., Josefa Benedetti Pharm.D., Darrel W. Hughes Pharm.D., FCCP
{"title":"Comment on “Professional and career development needs of clinical pharmacists in settings outside academia”","authors":"G. Christina Gutierrez Pharm.D.,&nbsp;Rebecca Brady Pharm.D.,&nbsp;Elizabeth O. Hand Pharm.D.,&nbsp;Josefa Benedetti Pharm.D.,&nbsp;Darrel W. Hughes Pharm.D., FCCP","doi":"10.1002/jac5.1990","DOIUrl":"https://doi.org/10.1002/jac5.1990","url":null,"abstract":"","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141583989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American College of Clinical Pharmacy : JACCP
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1